Cetera Trust Company, N.A Novartis Ag Transaction History
Cetera Trust Company, N.A
- $154 Billion
- Q4 2024
A detailed history of Cetera Trust Company, N.A transactions in Novartis Ag stock. As of the latest transaction made, Cetera Trust Company, N.A holds 3,627 shares of NVS stock, worth $362,808. This represents 0.23% of its overall portfolio holdings.
Number of Shares
3,627
Previous 3,687
1.63%
Holding current value
$362,808
Previous $424 Million
16.77%
% of portfolio
0.23%
Previous 0.26%
Shares
3 transactions
Others Institutions Holding NVS
# of Institutions
1,428Shares Held
131MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.22 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.2 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$810 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$699 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$577 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $215B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...